share_log

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target

HC Wainwright & Co.重申买入Arcturus Therapeutics,维持51美元的目标股价
Benzinga ·  2023/11/15 10:37

HC Wainwright & Co. analyst Ed Arce reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $51 price target.

HC Wainwright & Co. 分析师埃德·阿尔塞重申Arcturus Therapeutics(纳斯达克股票代码:ARCT)的买入并维持51美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发